
A collage photo of Jun Gong and Melissa Reimers
Jul 23, 2024, 00:19
Jun Gong: Podcast on mUC and how maintenance avelumab fits into the global 1L paradigm
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a post on X by EMD Serono adding:
“Was a delight doing this podcast with Melissa Reimers, Siteman Cancer Center and Washington University in St. Louis on mUC and how maintenance avelumab fits into the global 1L paradigm.
Published in: Springer Nature and Advances in Therapy.”
Quoting EMD Serono’s post below:
“Listen to two medical oncologists, Jun Gong and Melissa Reimers, as they provide their practical considerations in first-line treatments of patients with advanced urothelial carcinoma in this podcast.”
View the article attached to the post.
Sources: Jun Gong/X and EMD Serono/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 27, 2025, 17:56
Feb 27, 2025, 17:55
Feb 27, 2025, 17:54
Feb 27, 2025, 17:53
Feb 27, 2025, 17:49
Feb 27, 2025, 17:46
Feb 27, 2025, 17:13
Feb 27, 2025, 17:10